EHop-016 is a rac GTPase inhibitor. EHop-016 is a compound that blocks the interaction of Rac with the GEF Vav in metastatic human breast cancer cells. EHop-016 also inhibits the activation of the Rac downstream effector p21-activated kinase, extension of motile actin-based structures, and cell migration.